WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 THB
0,00%
(0,00) 1D
15. lis, 16:40:00 GMT+7 · THB
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za WUXI06...
Otvori
5,25 THB
Najviša
5,35 THB
Najniža
5,05 THB
Trž. kap.
207,48 mlr.
Prosj. kol.
93,60 tis.
Količina
288,50 tis.
52-tjed. najviša
6,25 THB
52-tjed. najniža
3,02 THB
Dionice u optjecaju
4,12 mlr.
Broj djelatnika
15 tis.
Otvori
5,25 THB
Najviša
5,35 THB
Najniža
5,05 THB
Trž. kap.
207,48 mlr.
Prosj. kol.
93,60 tis.
Količina
288,50 tis.
52-tjed. najviša
6,25 THB
52-tjed. najniža
3,02 THB
Dionice u optjecaju
4,12 mlr.
Broj djelatnika
15 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Naslovi.net
·
prije 1 dan
Wall Street: S&P 500 gotovo nepromijenjen nakon objava rezultata velikih banaka
Investor's Business Daily
·
prije 17 minuta
Anthropic Value Report Hits Tech Futures; Tesla Touts Roadster
The Motley Fool
·
prije 8 minuta
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics (Cayman) Inc. KKPS DR – informacije
Glavni izvršni direktorZhisheng Chen
Zaposlenici14,7 tis.
Osnovano2010
Sjedište-
Sektor-
Web-lokacijawuxibiologics.com